| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |